Surgery, especially cardiac surgery, is still a male domain. Until a few years ago, there was not a single female head of cardiac surgery in Germany. “But the picture is changing,” says Dr. Deniz.

Nitinol innovation in cardiac medtech is not slowing down in 2025, with innovative devices and systems hitting milestones and ...

Endospan today announced the presentation of 30-day results from a study evaluating its Nexus aortic arch stent graft system.

May 5, 2025Artivion, Inc. misses on earnings expectations. Reported EPS is $0.06 EPS, expectations were $0.12. Operator: Greetings. Welcome to Artivion's First Quarter 2025 Financial Conference Call.

Welcome to Artivion's first-quarter 2025 financial conference call. (Operator Instructions) Please note that today's conference is being recorded. At this time, I'll now turn the conference over to ...

Artivion presents new clinical data from NEXUS TRIOMPHE IDE trial at the 105th AATS Annual Meeting: Atlanta Tuesday, May 6, 2025, 13:00 Hrs [IST] Artivion, Inc., a leading cardiac ...

Endospan announced 30-day results of the statistical Dissection primary arm from the TRIOMPHE investigational device ...

Endospan today announced the presentation of 30-day results of the statistical Dissection Primary Arm from the TRIOMPHE Investigational Device Exemption (IDE) clinical study evaluating the NEXUS® ...

The Windows Section, which is about 2 square miles in size, is home to some of the largest arches in the park, including North Window, South Window, Turret Arch and Double Arch. It's also ...

Arch Manning is counting down the days. With his arrival at the University of Texas, the much-anticipated Manning era is set to begin. Soon, this third-generation Manning will take the field ...

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) announced today that the U.S. Food and Drug Administration (FDA) has approved its transcatheter aortic valve replacement (TAVR ...